DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol | Gene ID | Gene Name ▲ | UniProt ID |
---|---|---|---|---|---|
C0678222 | Breast Carcinoma | PIK3C2A | 5286 | phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 alpha | O00443 |
C0027651 | Neoplasms | PIK3C2A | 5286 | phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 alpha | O00443 |
C0027651 | Neoplasms | PIK3C2B | 5287 | phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta | O00750 |
C0376358 | Malignant neoplasm of prostate | PIK3C2B | 5287 | phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta | O00750 |
C0038454 | Cerebrovascular accident | PIK3C2B | 5287 | phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta | O00750 |
C0751606 | Adult Acute Lymphocytic Leukemia | PIK3C2B | 5287 | phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta | O00750 |
C0600139 | Prostate carcinoma | PIK3C2B | 5287 | phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta | O00750 |
C0017638 | Glioma | PIK3C2B | 5287 | phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta | O00750 |
C0036421 | Systemic Scleroderma | PIK3C2B | 5287 | phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta | O00750 |
C0019196 | Hepatitis C | PIK3C2B | 5287 | phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta | O00750 |
C1458155 | Mammary Neoplasms | PIK3C2B | 5287 | phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta | O00750 |
C0027819 | Neuroblastoma | PIK3C2B | 5287 | phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta | O00750 |
C0279626 | Squamous cell carcinoma of esophagus | PIK3C2B | 5287 | phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta | O00750 |
C1621958 | Glioblastoma Multiforme | PIK3C2B | 5287 | phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta | O00750 |
C0006142 | Malignant neoplasm of breast | PIK3C2B | 5287 | phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta | O00750 |
C0678222 | Breast Carcinoma | PIK3C2B | 5287 | phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta | O00750 |
C0030567 | Parkinson Disease | PIK3C2B | 5287 | phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta | O00750 |
C0023434 | Chronic Lymphocytic Leukemia | PIK3C2B | 5287 | phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta | O00750 |
C0149925 | Small cell carcinoma of lung | PIK3C2B | 5287 | phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta | O00750 |
C0700095 | Central neuroblastoma | PIK3C2B | 5287 | phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta | O00750 |
C0007131 | Non-Small Cell Lung Carcinoma | PIK3C2B | 5287 | phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta | O00750 |
C2239176 | Liver carcinoma | PIK3C2B | 5287 | phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta | O00750 |
C1306459 | Primary malignant neoplasm | PIK3C2G | 5288 | phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 gamma | O75747 |
C0020473 | Hyperlipidemia | PIK3C2G | 5288 | phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 gamma | O75747 |
C0006826 | Malignant Neoplasms | PIK3C2G | 5288 | phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 gamma | O75747 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024